Table 4.
Six-month hypertension treatment outcome in Syrian patients, Shatila primary care clinic, Beirut, Lebanon, 2016–2017
| Baseline BP | Six month BP | p-valuea | |
|---|---|---|---|
| SBP mmHg - [mean (SD); min-max] | |||
| HTN (n = 153) | 145 (23.9); 100–220 | 129 (18.7); 100–190 | <0.001 |
| HTN and DM ( n= 152) | 140 (22.3); 80–210 | 132 (23.2); 80–260 | <0.001 |
| DBP mmHg - [mean (SD); min-max] | |||
| HTN (n = 153) | 89 (15.0); 60–130 | 83 (10.8); 50–110 | <0.001 |
| HTN and DM (n = 152) | 86 (12.4); 50–110 | 82 (15.0); 50–180 | 0.011 |
| Controlled BP - [n (%)] | |||
| HTN (n = 153) | 42 (27) | 75 (49) | <0.001 |
| HTN and DM (n = 152) | 55 (36) | 79 (52) | 0.006 |
DBP diastolic blood pressure, DM diabetes mellitus, HTN hypertension, SBP systolic blood pressure, SD standard deviation
ap-value <0.05 is statistically significant; paired t-tests for mean and McNemar tests for proportions